News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Staff September 11, 2023 Continue Reading Previous Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T RelapseNext EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 More Stories Brain Clinical Trial Healthcare News Pharmaceutical Pregnancy Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients Staff November 23, 2024 Healthcare Hospitals News Nursing Patient Care Redefining the Standard of Care: Introducing the Aulisa® Monitor Camera for Advanced Patient Monitoring Staff November 23, 2024 Apps Financial Fitness News Nutrition Fitness App Market to Expand by USD 55.86 Billion (2024-2028), Driven by Health Management and Rising Chronic Disease Cases, AI Impacting Market Trends – Technavio Staff November 23, 2024
